Skip to content
Screener

Cencora COR EPS (Diluted)

EPS (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
$7.94+26.2%
McKesson logo
McKessonMCK
$5.15-17.6%
United Parcel Service, Inc. logo
United Parcel Service, Inc.UPS
$0.71-53.0%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
-$0.20-109%
AbbVie logo
AbbVieABBV
$2.03+290%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$0.18+157%

Other financials

Income statement

See full
Revenue$84.8B+5.1%
Gross profit$3.6B+24.1%
Operating income$1.1B+29.1%
Net income$763.5M+11.1%

Balance sheet

See full
Cash & equivalents$2.8B+26.1%
Total debt$11.7B+45.7%
Total equity$3.1B+54.1%
Total assets$83.8B+13.3%

Cash flow

See full
Operating cash flow$2.7B+2,329%
CapEx$226.0M+23.4%
Free cash flow$2.4B

Valuation

See full
Market cap$62.55B+11.0%
Enterprise value$71.46B+15.0%
P/E17.1×+3.5×
P/S0.2×0.0×

Profitability

See full
Gross margin4%+0.5pp
Operating margin0.9%0.0pp
Net margin0.6%-0.1pp
FCF margin1.1%+1.0pp

Returns & leverage

See full
Return on equity130.6%-99.8pp
Debt / equity3.8×-0.2×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cencora in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: Cencora’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 3:23 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001140859-26-000034
(in thousands, except per share data)Three months ended June 30, 2026Three months ended June 30, 2025Nine months ended June 30, 2026Nine months ended June 30, 2025
Net income attributable to Cencora, Inc.$763,518$687,402$2,964,497$1,893,873
Earnings per share:
Basic$3.95$3.55$15.28$9.77
Diluted$3.94$3.52$15.21$9.70
Weighted average common shares outstanding:
Basic193,147193,822193,971193,794
Diluted193,944195,230194,883195,172
Cash dividends declared per share of common stock$0.60$0.55$1.80$1.65

ITEM 1. Financial Statements (Unaudited)

FAQ

What is Cencora's EPS (diluted)?
Cencora (COR) reported EPS (diluted) of $3.94 in Q2 2026.
How has Cencora's EPS (diluted) changed year-over-year?
Cencora's EPS (diluted) increased by 11.9% year-over-year, from $3.52 to $3.94.
What is the long-term trend for Cencora's EPS (diluted)?
Over 3 years (2021 to 2024), Cencora's EPS (diluted) has grown at a 0.6% compound annual growth rate (CAGR), from $7.39 to $7.53.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about Cencora's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude